These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 30503627)

  • 1. Impact of an Acinetobacter baumannii outbreak on kidney events in a burn unit: A targeted machine learning analysis.
    Vauchel T; Pirracchio R; Chaussard M; Lafaurie M; Rouveau M; Rousseau C; Benyamina M; Soussi S; Dépret F; Ferry A; Oueslati H; Chaouat M; Mimoun M; Jarlier V; Moreno N; Mebazaa A; Legrand M
    Am J Infect Control; 2019 Apr; 47(4):435-438. PubMed ID: 30503627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence, risk factors, and outcome of multidrug-resistant Acinetobacter baumannii acquisition during an outbreak in a burns unit.
    Munier AL; Biard L; Rousseau C; Legrand M; Lafaurie M; Lomont A; Donay JL; de Beaugrenier E; Flicoteaux R; Mebazaa A; Mimoun M; Molina JM
    J Hosp Infect; 2017 Nov; 97(3):226-233. PubMed ID: 28751010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute kidney injury during colistin therapy: a prospective study in patients with extensively-drug resistant Acinetobacter baumannii infections.
    Durante-Mangoni E; Andini R; Signoriello S; Cavezza G; Murino P; Buono S; De Cristofaro M; Taglialatela C; Bassetti M; Malacarne P; Petrosillo N; Corcione A; Viscoli C; Utili R; Gallo C
    Clin Microbiol Infect; 2016 Dec; 22(12):984-989. PubMed ID: 27545697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence, risk factors and outcome of multi-drug resistant Acinetobacter baumannii nosocomial infections during an outbreak in a burn unit.
    Munier AL; Biard L; Legrand M; Rousseau C; Lafaurie M; Donay JL; Flicoteaux R; Mebazaa A; Mimoun M; Molina JM
    Int J Infect Dis; 2019 Feb; 79():179-184. PubMed ID: 30529108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors for nosocomial burn wound infection caused by multidrug resistant Acinetobacter baumannii.
    Tekin R; Dal T; Bozkurt F; Deveci O; Palanc Y; Arslan E; Selçuk CT; Hoşoğlu S
    J Burn Care Res; 2014; 35(1):e73-80. PubMed ID: 23799478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Use of Intravenous and Inhaled Colistin Therapy During a Burn Center Outbreak of Multidrug-Resistant Acinetobacter baumannii.
    Saun TJ; Rogers AD; Leis JA; Cartotto R
    J Burn Care Res; 2018 Oct; 39(6):1029-1036. PubMed ID: 28877134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiologic, clinical, and economic evaluation of an outbreak of clonal multidrug-resistant Acinetobacter baumannii infection in a surgical intensive care unit.
    Young LS; Sabel AL; Price CS
    Infect Control Hosp Epidemiol; 2007 Nov; 28(11):1247-54. PubMed ID: 17926275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multidrug-Resistant Bacterial Outbreaks in Burn Units: A Synthesis of the Literature According to the ORION Statement.
    Girerd-Genessay I; Bénet T; Vanhems P
    J Burn Care Res; 2016; 37(3):172-80. PubMed ID: 26056755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for 30-day mortality in patients with carbapenem-resistant Acinetobacter baumannii during an outbreak in an intensive care unit.
    Prates CG; Martins AF; Superti SV; Lopes FS; Ramos F; Cantarelli VV; Zavascki AP
    Epidemiol Infect; 2011 Mar; 139(3):411-8. PubMed ID: 20513254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated prevalence of multidrug-resistant Acinetobacter baumannii with extensive genetic diversity in the largest burn centre of northeast Iran.
    Sarhaddi N; Soleimanpour S; Farsiani H; Mosavat A; Dolatabadi S; Salimizand H; Amel Jamehdar S
    J Glob Antimicrob Resist; 2017 Mar; 8():60-66. PubMed ID: 28011349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors for the acquisition of imipenem-resistant Acinetobacter baumannii in a burn unit: An appraisal of the effect of colonization pressure.
    Cavalcante Rde S; Canet P; Fortaleza CM
    Scand J Infect Dis; 2014 Aug; 46(8):593-8. PubMed ID: 24918115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An outbreak of imipenem-resistant Acinetobacter baumannii in critically ill surgical patients.
    Fierobe L; Lucet JC; Decré D; Muller-Serieys C; Deleuze A; Joly-Guillou ML; Mantz J; Desmonts JM
    Infect Control Hosp Epidemiol; 2001 Jan; 22(1):35-40. PubMed ID: 11198020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors of multidrug-resistant, extensively drug-resistant and pandrug-resistant Acinetobacter baumannii ventilator-associated pneumonia in a Medical Intensive Care Unit of University Hospital in Thailand.
    Inchai J; Liwsrisakun C; Theerakittikul T; Chaiwarith R; Khositsakulchai W; Pothirat C
    J Infect Chemother; 2015 Aug; 21(8):570-4. PubMed ID: 26026660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reducing the spread of Acinetobacter baumannii and methicillin-resistant Staphylococcus aureus on a burns unit through the intervention of an infection control bundle.
    Barbut F; Yezli S; Mimoun M; Pham J; Chaouat M; Otter JA
    Burns; 2013 May; 39(3):395-403. PubMed ID: 22884127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An outbreak due to multiresistant Acinetobacter baumannii in a burn unit: risk factors for acquisition and management.
    Simor AE; Lee M; Vearncombe M; Jones-Paul L; Barry C; Gomez M; Fish JS; Cartotto RC; Palmer R; Louie M
    Infect Control Hosp Epidemiol; 2002 May; 23(5):261-7. PubMed ID: 12026151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outbreak of resistant Acinetobacter baumannii- measures and proposal for prevention and control.
    Romanelli RM; Jesus LA; Clemente WT; Lima SS; Rezende EM; Coutinho RL; Moreira RL; Neves FA; Brás Nde J
    Braz J Infect Dis; 2009 Oct; 13(5):341-7. PubMed ID: 20428632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outbreak of imipenem-resistant Acinetobacter calcoaceticus-Acinetobacter baumannii complex harboring different carbapenemase gene-associated genetic structures in an intensive care unit.
    Lee YT; Fung CP; Wang FD; Chen CP; Chen TL; Cho WL
    J Microbiol Immunol Infect; 2012 Feb; 45(1):43-51. PubMed ID: 22169123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcome analysis of colistin-treated burn center patients.
    Wilkinson RE; Hill DM; Hickerson WL
    Burns; 2017 Sep; 43(6):1244-1249. PubMed ID: 28410932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of a modified cleaning procedure in the prevention of carbapenem-resistant Acinetobacter baumannii clonal spread in a burn intensive care unit using a high-sensitivity luminometer.
    Casini B; Selvi C; Cristina ML; Totaro M; Costa AL; Valentini P; Barnini S; Baggiani A; Tagliaferri E; Privitera G
    J Hosp Infect; 2017 Jan; 95(1):46-52. PubMed ID: 27939245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outbreak of imipenem-resistant Acinetobacter baumannii in different wards at a regional hospital related to untrained bedside caregivers.
    Wang CH; Li JF; Huang LY; Lin FM; Yang YS; Siu LK; Chang FY; Lin JC
    Am J Infect Control; 2017 Oct; 45(10):1086-1090. PubMed ID: 28549878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.